Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity
Click here to view the article on PubMed. The Gorlin [...]
Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center
Click here to view the article on PubMed. The Gorlin [...]
Illuminating Alternative Strategies to Treat Targeted Chemotherapy-Resistant Sporadic Basal Cell Carcinoma
Click HERE to view the article on PubMed.gov. The Gorlin Syndrome [...]
Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity
Click HERE to view the article in the Journal of [...]
Beyond the Creams and Cutting Webinar
The GSA hosted our first webinar on Thursday, February 28th. [...]
Specific temperament in patients with nevoid basal cell carcinoma syndrome
Click HERE to view the article on PubMed. The Gorlin [...]
Blood Donation and Gorlin Syndrome
The statements below are approved by GSA's Medical and Scientific [...]
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
Click HERE to view the article on PubMed.gov. The Gorlin Syndrome [...]
The Gorlin Syndrome Alliance and NORD Launch Natural History Study for Gorlin Syndrome
Click HERE to read the NORD press release. Click HERE [...]
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
Click here to read the article on the BMC Cancer [...]